Bipartisan Sense on Patent Office Bias


By James Edwards

The Patent and Trademark Office, the federal agency charged with securing certain intellectual property, has become an enemy of America's inventors.

How is it that an office charged with protecting innovation is subverting it?

In 2011, Congress passed the America Invents Act. This law included a number of provisions harmful to IP rights.

Perhaps the worst was the establishment of new administrative procedures for challenging a patent's validity. The abuse of this system has reached epidemic proportions. It's time for Congress to restore integrity to the patent system.

The new administrative process for challenges to existing patents, known as inter partes review, centers on a review by the Patent Trial and Appeal Board, which proponents sold as a faster, cheaper alternative than taking patent challenges to court. The trouble is that PTAB proceedings are wildly unbalanced in favor of patent challengers.

Federal court procedures provide a balanced, fair process and operate on a presumption that the patent, having been duly granted after review by the PTO, is valid. Yet the IPR procedures at PTAB, as one commenter put it, "are plagued by what in any other forum would be considered to be 'procedural irregularity.'"

First, anybody may file a PTAB challenge. This has enabled speculators, such as hedge funds with no interest in the patent or invention, to short the stock of a patent owner, then file for review simply to make a profit on the devalued stock.

Second, PTAB sets a low standard of proof, so petitioners can easily wipe out property rights. This differs from the tougher standards in federal courts.

Finally, there's no protection of a challenged patent from "double jeopardy." At PTAB, a patent may be challenged again and again. Thus, a patent owner may face a never-ending battle.

The same patent can face a challenge in both the PTAB and federal district court. A federal court's decision to uphold a patent doesn't preclude PTAB from instituting a proceeding on the same patent -- or even from overruling the court.

Should the patent owner prevail, the victory consists entirely of the right to keep the patent -- no damages or expenses. Only now, precious time has been lost on the patent term

What has the PTAB regime led to, besides a clear and present danger to secure private property rights? More than one in three patents hauled into IPR has faced more than one request for review. Companies whose business centers on intellectual property frequently find themselves facing one or several IPR actions each time they seek to defend their patent rights.

The IPR process invalidates an incredible 76 percent of the patent claims challenged. In contrast, district courts toss out 30 percent of challenged claims. Such uncertainty has devalued patents by two-thirds since the AIA became law.

Thankfully, bipartisan legislation would address many of the excesses of the PTAB regime. The STRONGER Patents Act brings the balance and fairness of the federal courts to administrative challenges to patents.

Nobody but lawyers likes expensive litigation. But if something entails high stakes -- for example, billions of R&D dollars, years of trial and error, and the potential revocation of someone's property rights -- the proceedings making the determination between disputing parties must be fair. As it currently operates, PTAB isn't.

James Edwards is executive director of Conservatives for Property Rights and advises Eagle Forum Education and Legal Defense Fund on patent issues.

More Resources


04/28/2024
1968 Protests Should Serve as a Warning to Today's Democrats


more info


04/28/2024
Is the Worst Yet to Come?
By Steve Huntley April 28, 2024 This and that. Random thoughts and observations about current events. Trigger alert! What follows might harm the psyche of the woke. Perhaps those sensitive souls should retreat to a safe space, which I suspect will be Judenfrei. Peaceful protest is a hallowed right and tradition in America. These days, however, that right, which achieved ... Read More

more info


04/28/2024
Who's on Trial, a Former President or a Mob Boss?
It's downright disturbing to contemplate the similarities between the Donald's hush money trial and that of an organized crime don.

more info


04/28/2024
Public Worried Dems Engaging in Politicized Lawfare


more info


04/28/2024
Even Bill Barr Should Prefer Joe Biden
Even Bill Barr Should Prefer Joe Biden

more info


04/28/2024
The Economy: From Bad to Worse--Stagflation
Consumer spending has slowed, capital investment slowed, inventories slumped - and the trade deficit widened.

more info


04/28/2024
Biden's Dilemma: NC Voters Are Sour on Economy
All indicators are up, except the one that matters most to Biden's reelection

more info


04/28/2024
Campus Leaders Must Show Courage, Stand Up to Hatred
Signs at Columbia University read Go Back to Poland, calling for the Jewish community to return to the horrific death camps of the Holocaust.

more info


04/28/2024
The Campus-Left Occupation That Broke Higher Education
Elite colleges are now reaping the consequences of promoting a pedagogy that trashed the postwar ideal of the liberal university.

more info


04/28/2024
Education Apocalypse Now?
The Ivy League Hits An Iceberg.

more info


04/28/2024
The Strange Death of the Family
The world is sleepwalking towards a depopulation crisis.

more info


04/28/2024
Alvin Bragg and the Art of Not Taking the Law Too Seriously


more info


04/28/2024
Justice Alito Is Holding Trump to a Different Standard
I mentioned it in passing in my Friday column, but I was struck - disturbed, really - by one specific

more info


04/28/2024
Shock and Awe on the Campaign Trail


more info


04/28/2024
Disillusionment Plagues Young Latinos in Swing States


more info



Custom Search

More Politics Articles:

Related Articles

Congress: Let's Talk About Trade Enforcement


The Trump administration has set an ambitious trade agenda for the remainder of 2020. In a House Ways and Means Committee hearing earlier this summer, U.S. Trade Representative Robert Lighthizer stressed the president's intent to crack down on foreign countries that discriminate against American business and innovators.

With Biomedical Research, Taxpayers are Getting a Great Deal


Gilead Sciences' novel drug remdesivir has shown immense promise for treating coronavirus. Yet every time a company develops a promising drug, some policymakers call for the government to take control of the compound in question.

Marx on Christianity, Judaism, and Evolution/Race


"If someone calls it socialism," said the Rev. William Barber at an August 2019 conference of the Democratic National Committee, "then we must compel them to acknowledge that the Bible must then promote socialism, because Jesus offered free health care to everyone, and he never charged a leper a co-pay."

Abusing March-in Rights Would Jeopardize COVID-19 Research


Thirty-one state attorneys general recently urged the Trump administration to disregard the intellectual property protections on remdesivir -- the only FDA-approved treatment for COVID-19 -- and then license its patents to multiple drug manufacturers.

Judge Amy Coney Barrett and the Purdue Sexual Assault Case


Will some senators on the Senate Judiciary Committee vilify Judge Amy Coney Barrett, President Trump's Supreme Court nominee? Attacks on her religion, her large family, or claims that she will block the advance of women may make good fodder for Facebook, but senators who pursue those tacks are likely to reap public disapproval from their own constituents. What is more likely is that liberal senators will take a page from liberal/progressive organizations like Public Justice and portray Barrett as soft on and complicit with campus sexual abusers. How?

President Trump's Executive Order Will Put an End to Pharmaceutical Breakthroughs


Every day, scientists get closer to a COVID-19 vaccine. A handful of biopharmaceutical firms hope to make one available by year's end.

The Mayflower Mystique: Remembering the Pilgrims


Few can name which groups the Godspeed and the Arabella brought to America. They were the Jamestown colonists in 1607 and the Puritans to Massachusetts Bay Colony in 1630, respectively. But the Mayflower, which brought the Pilgrims to Plymouth in 1620, has sailed into history and ranks with the Titanic, the Lusitania, the Bismarck, and the Queen Mary as the world’s most famous ships. What accounts for the Mayflower’s mystique?

COVID's Second Wave Underscores the Threats Facing Disabled Americans


The second wave of COVID-19 has arrived with a vengeance.

Triumph of the Vaccine—No Shape-Shifting Enemy


Here’s a thought experiment. What if our experience with COVID-19 turns out to be a warm-up for responding to a worse plague in the future? COVID-19 is devastating for a significant number of older people but relatively innocuous for the young. I am thankful that this is not like the Justinian plague, nor the Athenian one, nor like smallpox. What if—God forbid—we find ourselves hosting a plague like one of these? Something as deadly as Ebola but as infectious as SARS-CoV-2?

Who is Perfect? Biden, Trump, McConnell, Pelosi?


Democrats have proven once again that they can find fault in President Donald Trump. Faults and flaws were found in him before the election. Many years before politics there were never any rave reviews about him being perfect.

The 340B Prescription-Drug Swindle Has Gone on Long Enough


In a recent hearing, California Attorney General Xavier Becerra revealed just how unfit he is to lead the Department of Health and Human Services.

Vaccination is the Ticket to Getting the U.S. Back On Track


The end of the pandemic in the U.S. is in sight. The Covid-19 vaccines currently available in the United States have proven to be outstandingly effective at protecting recipients from coronavirus and they are also safe.

Private Deborah Sampson, 'The Female Soldier'


There are those who would say that Private Deborah Sampson deserved the Medal of Honor, but she didn’t sign up for that; she joined the Army to fight for her country and wound up making history. Private Sampson was America’s first woman combat soldier. She served, disguised as a man by the name of Robert Shurtleff, under the command of General George Washington in the Continental Army during the American Revolution.

The End of Covid-19 Could Start in the Hair Salon


President Biden has floated an ambitious goal -- vaccinate enough Americans to achieve some sense of normalcy by July 4.

President Biden Is Right to Redefine Infrastructure


President Biden is in ongoing talks to discuss his multi-trillion-dollar infrastructure plan. Ever since its release, critics have claimed that many aspects of the plan have nothing to do with infrastructure.

America Needs Strong Patent Laws to Keep Inventing


In May, the Biden administration announced its support for a proposal at the World Trade Organization to suspend international intellectual property protections on Covid-19 vaccines.